GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » Price-to-Operating-Cash-Flow

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Price-to-Operating-Cash-Flow : (As of Jun. 05, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings Price-to-Operating-Cash-Flow?

As of today (2024-06-05), Cannabis Bioscience International Holdings's share price is $0.0008. Cannabis Bioscience International Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Nov. 2023 was $0.00. Hence, Cannabis Bioscience International Holdings's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Cannabis Bioscience International Holdings's Price-to-Operating-Cash-Flow or its related term are showing as below:

CBIH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0.01   Med: 0.37   Max: 3.7
Current: 0.05

During the past 5 years, Cannabis Bioscience International Holdings's highest Price-to-Operating-Cash-Flow Ratio was 3.70. The lowest was 0.01. And the median was 0.37.

CBIH's Price-to-Operating-Cash-Flow is ranked better than
99.85% of 682 companies
in the Drug Manufacturers industry
Industry Median: 16.105 vs CBIH: 0.05

Cannabis Bioscience International Holdings's Cash Flow from Operations per share for the six months ended in Nov. 2023 was $0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Nov. 2023 was $0.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Cannabis Bioscience International Holdings was -100.00% per year.

During the past 5 years, Cannabis Bioscience International Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was -94.50% per year. The lowest was -94.50% per year. And the median was -94.50% per year.


Cannabis Bioscience International Holdings Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Cannabis Bioscience International Holdings's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings Price-to-Operating-Cash-Flow Chart

Cannabis Bioscience International Holdings Annual Data
Trend Dec06 Dec07 May09 May10 May11
Price-to-Operating-Cash-Flow
- - - - 27.78

Cannabis Bioscience International Holdings Semi-Annual Data
Dec06 Jun07 Dec07 Jun08 May09 Nov09 May10 Nov10 May11 Nov11 Nov22 Nov23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 27.78 1.30 - -

Competitive Comparison of Cannabis Bioscience International Holdings's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Bioscience International Holdings's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's Price-to-Operating-Cash-Flow falls into.



Cannabis Bioscience International Holdings Price-to-Operating-Cash-Flow Calculation

Cannabis Bioscience International Holdings's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.0008/0
=

Cannabis Bioscience International Holdings's Share Price of today is $0.0008.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cannabis Bioscience International Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Nov. 2023 was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Cannabis Bioscience International Holdings Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6201 Bonhomme Road, Suite 466S, Houston, TX, USA, 77036
Cannabis Bioscience International Holdings Inc is engaged in providing educational systems relating to cannabis and services in therapeutic areas. of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. The Company generates revenue from multiple streams, namely, clinical trials, consulting fees, video courses, seminars, royalties, and merchandise sales. The company generates the majority of its revenue from clinical trials.